US$ 25.05
glp-1 drugs for parkinson's disease Are we measuring the wrong primary outcome for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep If GLP-1 Drugs Are Good
Description
de Souza, G.A

Read source Hunter, G

Maybe these meds have been a nightmare and youre feeling more confused than ever

Belli, M

At La Jolla Recovery, we integrate the latest neuroscience into our treatment approach because we know that recovery is not one-size-fits-all
